| Authors: |
Tenuta M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Bravo M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Olson A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Saney CL; Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA., Weinfurter J; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA., Ben-Akiva E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Bhange D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Cottrell CA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA, USA., Vosler L; Immunology Services, Wisconsin National Primate Research Center, Madison, WI, USA.; AIDS Vaccine Research Laboratory, University of Wisconsin, Madison, WI, USA., Weisgrau K; Immunology Services, Wisconsin National Primate Research Center, Madison, WI, USA.; AIDS Vaccine Research Laboratory, University of Wisconsin, Madison, WI, USA., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; The Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., Irvine DJ; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA, USA.; The Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Moderna, Cambridge, MA, USA., Rakasz E; Immunology Services, Wisconsin National Primate Research Center, Madison, WI, USA.; AIDS Vaccine Research Laboratory, University of Wisconsin, Madison, WI, USA., Joyner CJ; Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA, USA. cjjoyne@uga.edu.; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA. cjjoyne@uga.edu.; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA. cjjoyne@uga.edu., Voss JE; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. jvoss@scripps.edu. |
